BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting

- Scolyer, Richard A., Atkinson, Victoria, Ch'ng, Sydney, Colebatch, Andrew J., Daneshvar, Dariush, Pires da Silva, Ines, Dawson, Tamara, Ferguson, Peter M., Foster-Smith, Erwin, Fox, Stephen B., Gill, Anthony J., Gupta, Ruta, Gyorki, David E., Henderson, MA, Hong, AM, Howle, JR, Jackett, LA, James, C, Lee, CS, Lochhead, A, Loh, D, McArthur, GA, McLean, CA, Lambie, Duncan, Menzies, AM, Nieweg, OE, O'Brien, BH, Pennington, TE, Potter, AJ, Prakash, S, Rawson, RV, Read, RL, Rtshiladze, MA, Shannon, KF, O'Toole, Sandra, Smithers, BM, Spillane, AJ, Stretch, JR, Thompson, JF, Tucker, P, Varey, AHR, Vilain, Ricardo E., Wood, BA, Long, GV, Saw, Robyn P. M., Amanuel, Benhur, Angel, Christopher M., Button-Sloan, Alison E., Carlino, Matteo S.

Metastatic acral melanoma treatment outcomes: A systematic review and meta-analysis

- Cho, Kenneth K., Cust, Anne E., Foo, Yun Megan, Long, Georgina V., Menzies, Alexander M., Eslick, Guy D.

Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers

- Navani, Vishal, Graves, Moira C., Marchett, Giovana Celli, Mandaliya, Hiren, Bowden, Nikola A., van der Westhuizen, Andre

Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma

- Carlino, Matteo S., Gowrishankar, Kavitha, Rizos, Helen, Saunders, Catherine A. B., Pupo, Gulietta M., Snoyman, Stephanie, Zhang, Xu Dong, Saw, Robyn, Becker, Therese M., Kefford, Richard F., Long, Georgina V.

The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance

- Wroblewski, David, Mijatov, Branka, Mohana-Kumaran, Nethia, Lai, Fritz, Gallagher, Stuart J., Haass, Nikolas K., Zhang, Xu Dong, Hersey, Peter

P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation

- Avery-Kiejda, Kelly A., Bowden, Nikola A., Hersey, Peter, Croft, Amanda J., Scurr, Lyndee L., Kairupan, Carla F., Ashton, Katie A., Talseth-Palmer, Bente A., Rizos, Helen, Zhang, Xu D., Scott, Rodney J.

Immunotherapy of distant metastatic disease

- Schadendorf, D., Algarra, S. M., Schachter, J., Hersey, P., Bastholt, L., Cinat, G., Dreno, B., Eggermont, A. M. M., Espinosa, E., Guo, J., Hauschild, A., Petrella, T.